Opening The Floodgates: SRC-3's Role In Regulatory T Cell Suppression
Understanding the role of an essential protein inside regulatory T cells could be critical in reverse-engineering a treatment for solid tumors.
Stay updated with breaking news from Solid Tumor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Understanding the role of an essential protein inside regulatory T cells could be critical in reverse-engineering a treatment for solid tumors.
Research on regulatory T cells is building towards a durable and long-lasting treatment for many solid cancers.
Median overall survival for GPS and Keytruda® combination was 18.4 Months compared to 13.8 Months in a Keytruda® single agent study (KEYNOTE-028) and 11-14...
BPRDPO-56 is under clinical development by Molecular Targeting Technologies and currently in Phase I for Solid Tumor.
NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel